NEW YORK, March 03, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of USANA Health Sciences, Inc. ("USANA") (NYSE:USNA) between March 14, 2014 and February 7, 2017. You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of Utah. To get more information go to:
http://www.zlk.com/pslra/usana-health-sciences-inc
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts, including that: (i) the Company's BabyCare Ltd. subsidiary had engaged in improper reimbursement practices in China; (ii) these practices constituted violations of the Foreign Corrupt Practices Act; (iii) as such, the Company’s China revenues were in part the product of unlawful conduct and unlikely to be sustainable; (iv) the foregoing conduct was likely to subject the Company to significant regulatory scrutiny; and (v) as a result of the foregoing, USANA’s public statements were materially false and misleading at all relevant times
On February 7, 2017, post-market, USANA disclosed that “[t]he Company is voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare's expense reimbursement policies.”
If you suffered a loss in USANA you have until April 14, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


John Ternus Signals Apple’s Future with Product-First AI Strategy
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries”
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
Want to cut your energy bills? Here’s how five experts are doing it
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 



